Carnitine supplements may be advisable not only in premature but also in ar
tificially-fed full-term babies. The acyl-carnitine/free carnitine (AC/FC)
and FC/total camitine (FC/TC) ratios have been considered markers of "carni
tine insufficiency" and "carnitine deficiency", respectively. Values of AC/
FC > 0.40 are considered abnormal and mean that FC has a low bioavailabilit
y to the cells and so reflects a "carnitine insufficiency". Values of FC/TC
< 0.7 indicate "carnitine deficiency". We analyze the validity of such rat
ios and the limits for them in three groups of full-term neonates (n = 66):
22 breast-fed (BF), 22 with formula (F); and 22 fed with carnitine-supplem
ented formula. Several studies have shown the need to give supplements of c
arnitine to the neonate because of its "essentiality", but no one has demon
strated the adequate dosages. We therefore propose to establish new limit l
evels for these ratios to control carnitine nutritional status in neonates,
based on the control of percentile ranges for normal BF infants (in this s
tudy: 97th percentile of AC/FC > 0.83; 3rd percentile of FC/TC < 0.54) and
on evaluating the needs of neonates and dosages required to supplement F. T
he supplement of 2.2 mg of L-carnitine/100 ml in the cow's milk formula use
d in the present study produces a similar biochemical pattern of plasma car
nitine and ACs to that observed in BF infants, together with a lower risk o
f developing "carnitine deficiency" or "carnitine insufficiency" than those
babies fed with nonenriched F. Considering that human milk is the best sou
rce of nutrition for full-term infants, the limit established for AC/FC and
FC/TC ratios at other ages of life seems to be "inadequate" for neonates.
(C) 1998 Elsevier Science ireland Ltd. All rights reserved.